#Europe Plasma Fractionation Market | Explore Tumblr posts and blogs

communicationblogs · 1 month ago

Text

Argon Gas Market — Forecast(2024–2030)

Argon Gas Market Overview

Argon Gas Market is forecast to reach $597.5 million by 2030, after growing at a CAGR of 5.2% during 2024–2030. Cryogenic fractional distillation and gas chromatography are the most common methods for producing argon gas. Rising consumption and demand from the growing metal manufacturing industry for argon gas, coupled with increasing industrialization, especially in emerging economies are the major factors expected to drive the growth of the Argon Gas Market. Due to the rising demand for argon gas in numerous application segments such as electronics, stainless steel, and fabricated metalworking, the Argon Gas Market is expected to grow globally. Furthermore, technological innovation such as the increasing use of electrospray ionization mass spectrometry in the healthcare industry is anticipated to create new opportunities for the growth of the global argon gas industry in the forecast era. Argon gas finds extensive use in electronics manufacturing, particularly in the production of semiconductors and other electronic components. The trend is driven by the need for a controlled atmosphere during processes like sputtering and plasma etching.

Request Sample

The semiconductor industry’s continuous growth is propelling the demand for high-purity Argon, contributing to market expansion. The healthcare sector is increasingly adopting Argon gas for medical applications, including cryopreservation and laser surgeries. Argon’s inert properties make it suitable for preserving biological samples, while its use in medical lasers ensures precision and minimal tissue damage. With advancements in medical technology, the healthcare industry is becoming a significant consumer of Argon gas, driving market growth.

Impact of Covid-19

The consequences of the pandemic are altering Argon Gas Markets, as some manufacturers are either shutting down or reducing their supply due to a lack of demand from the downstream industry. Thus, this has led to a decline in the market growth for argon gas over the year 2020–21.

Argon Gas Market Report Coverage

The: “Argon Gas Market Report — Forecast (2024–2030)”, by IndustryARC, covers an in-depth analysis of the following segments of the Argon Gas Market.

By Grade: Food Grade, Industrial Grade, Scientific Grade, and Others

By Mixture: Argon-carbon dioxide, Argon-oxygen, Argon-nitrogen, Argon-hydrogen, and Others

By Function: Insulation, Illumination, and Cooling

By Application: Manufacturing & Fabrication, Lighting, 3-D printing, Lasers, Gas dischargetubes, Cinematography, Refrigeration, Windows, Tire

By End-Use Industry: Chemical Industry, Healthcare Industry, Transportation Industry, Food & Beverage Industry, Electrical & Electronics Industry, and Others

By Geography: North America (U.S, Canada, and Mexico), Europe (U.K., Germany, France, Italy, Netherlands, Spain, Russia, Belgium, and Rest of Europe), APAC (China, Japan, India, South Korea, Australia, Taiwan, Indonesia, Malaysia, and Rest of Asia Pacific), South America (Brazil, Argentina, Colombia, Chile, and Rest of South America), and RoW (Middle East and Africa)

Inquiry Before Buying

Key Takeaways

● The Asia Pacific region dominated the argon gas market due to the rapidly growing fabrication industries and the rising demand for argon gas from the food & beverage and healthcare sectors.

● Increasing use of argon gas owing to its greater thermal protection properties than air, for filling the dry suits used for scuba diving is anticipated to increase the demand for the argon gas market in the forecast period.

● Since Argon gas provides the inert atmosphere needed for rapid material cooling and heating, it is used in the electronics industry for the manufacture of semiconductors, flat panels, solar PV cells and microelectronic devices.

● Rising cause of inert gas asphyxiation among the workers by the consumption of argon gas in the absence of oxygen is anticipated to decline the growth of the market.

Argon Gas Market Segment Analysis — By Grade

Industrial grade held the largest share in the argon gas market in 2023. In MIG and TIG welding methods and plasma cutting applications due to its high density and absolute inertness, industrial-grade argon gas is widely used as a welding gas. Industrial-grade argon gas is supplied in gas bottles and cylinders of various sizes to suit consumer needs. Industrial-grade argon gas has many different applications in many industries. The most common application is either in pure form or as part of different mixtures, as a shielding gas for arc welding. Industrial-grade argon gas is one of the major gases for incandescent (filament) lamps, phosphorescent tubes, and thyratron radio tubes used in filling mixtures. Thus, with the rising demand for industrial-grade argon gas, the overall market is anticipated to rise in the forecast period.

Argon Gas Market Segment Analysis — By Mixture

Argon-carbon dioxide mixture is widely used in the argon gas market. Argon-carbon dioxide is a colorless, odorless, and non-flammable gas mixture. Argon mixtures with carbon dioxide are universal and are ideal for low-treated and stainless steel welding. One of the key composite components of safe welding mixtures is argon. Protective gas protects the electrode, metal, and hot metal near the welding seam from the ambient air as well as enhances the welding process and increases the welding characteristics. Argon-carbon dioxide blends can be used to incorporate a large spectrum of material thicknesses with a number of metal transition modes. With the rising use of argon-carbon dioxide mixture due to its unique properties, the market for argon gas is estimated to rise over the projected period.

Argon Gas Market Segment Analysis — By Function

Insulation function is highly preferred in the argon gas market. Argon serves as a barrier to prevent the indoor heat from escaping, like most insulating materials. But unlike most gases, the higher density of argon has greater thermal efficiency. This slow-moving gas, keeping heat loss to a minimum, allows less convection. To improve the energy consumption and general performance of thermal windows, argon gas is used. Insulated windows that are filled with argon gas are less likely to produce condensation. This is particularly true in areas of high humidity, such as the kitchen and the bathroom. Although good energy conservation could be demonstrated by fogging on the exterior surface of the glass, excessive humidity could result in water damage. With argon, to prevent it from sweating, the middle and the edges of the window glass will remain above the dew mark.

Argon Gas Market Segment Analysis — By Application

Manufacturing & Fabrication sector held the largest share in the argon gas market in 2023 and is projected to grow at a CAGR of 4.7% during the forecast period 2024–2030. During arc welding, it is often used as a shielding gas, because it shields the metal that is being worked on from oxygen. TIG, which stands for ‘tungsten inert gas’, utilizes both pure argon and argon mixtures. Argon decreases the chromium losses in the manufacture of steel in a converter, ensuring the desired carbon content can be reached at a lower and lower temperature. In aluminum processing, argon is often used to extract and degasify hydrogen. Also, cryogenic fractional distillation is used for producing argon gas of high purity, which is further used for the manufacturing and fabrication of semiconductor devices. Therefore, the rising demand for argon gas from the manufacturing and fabrication sector will drive the market demand for argon gas to grow in the forecast period.

Buy Now

Argon Gas Market Segment Analysis — By End-Use Industry

Automotive industry held the largest share of the argon gas market in 2023. Argon, due to its inert properties, is used in a wide variety of applications to help improve quality as well as maximize performance and yield in the manufacture of automotive parts. Owing to its alluring properties such as reduction or elimination of surface oxidation, improvement in part quality, decreasing scrap, and increasing efficiency and yields, it is used in a wide range of applications across automotive component manufacturing such as for welding, thermal, and plasma spraying, 3D printing, quenching, and others. Also, the most exotic use of argon is in the tires of luxury vehicles. Not only does the gas shield the tires from an oxygen attack, but it also provides less tire noise while the vehicle is moving at speed. With the rising automotive industry, the application of argon gas in the production of automotive components will also increase. According to the Association of Automobile Manufacturers (CAAM), China’s auto exports reached a record high of 4.91 million vehicles in 2023, up 57.9 percent year over year, as the nation’s automakers increased their global footprint. Thus, the rising demand for argon gas from the automotive industry is further estimated to raise the market growth.

Argon Gas Market Segment Analysis — Geography

For More Details on This Report — Request for Sample

Argon Gas Market Drivers

Increasing Price of Helium is Driving the Demand for Argon as an Alternative for Various Applications

Helium is replaced by argon in various sectors. Due to the high cost relative to argon, which has low cost and also has large applications, rising helium prices are expected to propel argon demand in many regions. Argon is used instead of helium because of the rising demand in separate application categories, such as stainless steel, electronics, and industrial metalworking sectors. According to the Oil Prices News Article in 2023, Helium prices skyrocketed when expectations of an abundant supply were not met; depending on purity and grade, they can sell for $500 Mcf to $1,000/Mcf. Prices are still ambiguous and change from transaction to transaction. Argon may be replaced by helium in the welding process. Also, helium is commonly used as a shielding gas for non-ferrous welding. Instead of helium, argon may be used and is favored by some metal forms. Owing to the above factors, an increase in demand for argon as an alternative to helium will drive the market for argon gas in the forecast period.

Rising Demand for Argon Gas in the Healthcare Industry

Cryogenic fractional distillation is used for the production of large quantities of purified argon in the healthcare industry. Argon is a noble gas component that has shown valuable narcotic and defensive capability in the medical sector. In order to selectively kill small areas of diseased or unhealthy tissue, especially on the skin, Argon is used to conduct accurate cryosurgery, which requires intense cold. Very cold argon is generated by controlled expansion of argon gas at the site and is driven using a cryoneedle to the treatment stage. This gives the device greater control than older liquid nitrogen techniques. A similar technique, cryoablation, is used to treat heart arrhythmia by destroying cells that interfere with the normal distribution of electrical impulses. As an important technique in clinical laboratories, electrospray ionization mass spectrometry (ESI-MS) has arisen. The increasing growth of argon in healthcare industries is expected to influence major trends in the global argon gas market in the coming years.

Argon Gas Market Challenges

Health Effects of Argon Gas Acts as a Constraint Towards the Growth of the Market

Argon gas can be absorbed into the body through inhalation. This liquid evaporates very rapidly with the lack of containment, creating air supersaturation and a significant risk of suffocation while in confined areas. Argon gas has been categorized as simple inert gas asphyxiation. Excessive inhalation can lead to dizziness, nausea, vomiting, loss of consciousness, and death. Death can result from mistakes that prevent self-rescue in judgment, misunderstanding, or lack of consciousness. Unconsciousness and death can occur in seconds without warning at low oxygen concentrations. Also, contact with argon gas can irritate and burn the skin and eyes. Very high levels of argon can decrease the amount of oxygen in the air and cause suffocation with symptoms of headache, rapid breathing, and loss of coordination and judgment. Hence, various harmful effects of argon gas on humans will further create hurdles for the argon gas market in the forecast period.

Market Landscape

● Technology launches, acquisitions and R&D activities are key strategies adopted by players in the argon gas market. Major players in the argon gas market are Taiyo Nippon Sanso Corporation, The Linde Group, Iwatani Corporation, Messer Group GmbH, Air Liquid S.A., SABIC, BASF SE, Air Products, and Space Cryogases Private Limited. and Matheson Tri-Gas Inc. among others.

Acquisitions/Technology Launches

• In October 2023, Inox Air Products intends to invest between Rs 300 and Rs 500 crore to build a supply network and purifying facilities for gases used by Indian semiconductor production facilities. Inox Air Products has started making investments in the purification of raw gases, such as oxygen, nitrogen, argon, helium, nitrous oxide, methane, silane, and ammonia, that are currently available in India. We’ll transform these gases into ultra-high purity.

#reseach marketing #marketing #research #digital marketing #chemicals #japan #usa

0 notes

globalgrowthinsights · 4 months ago

Text

Curved Televisions Market Size, Share, Demand, Growth and Forecast 2024-2032

Curved Televisions Market provides in-depth analysis of the market state of Curved Televisions manufacturers, including best facts and figures, overview, definition, SWOT analysis, expert opinions, and the most current global developments. The research also calculates market size, price, revenue, cost structure, gross margin, sales, and market share, as well as forecasts and growth rates. The report assists in determining the revenue earned by the selling of this report and technology across different application areas.

Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth Rate of Curved Televisions in these regions till the forecast period

North America

Middle East and Africa

Asia-Pacific

South America

Europe

Key Attentions of Curved Televisions Market Report:

The report offers a comprehensive and broad perspective on the global Curved Televisions Market.

The market statistics represented in different Curved Televisions segments offers complete industry picture.

Market growth drivers, challenges affecting the development of Curved Televisions are analyzed in detail.

The report will help in the analysis of major competitive market scenario, market dynamics of Curved Televisions.

Major stakeholders, key companies Curved Televisions, investment feasibility and new market entrants study is offered.

Development scope of Curved Televisions in each market segment is covered in this report. The macro and micro-economic factors affecting the Curved Televisions Market

Advancement is elaborated in this report. The upstream and downstream components of Curved Televisions and a comprehensive value chain are explained.

Browse More Details On This Report at @https://www.globalgrowthinsights.com/market-reports/curved-televisions-market-100561

Global Growth Insights

Web: https://www.globalgrowthinsights.com

Our Other Reports:

Plasma Fractionation MarketMarket Forecast

Global Serial EEPROM MarketMarket Size

Software Development Services MarketMarket Growth

Medium Molecular Weight Polyisobutylene (PIB) MarketMarket Analysis

Protein Purification MarketMarket Size

Global Motor For Robots MarketMarket Share

Global Premium Spirit MarketMarket Growth

Personal Cloud MarketMarket

Bird Detection System MarketMarket Share

Wireless Charging System for Electric Vehicles MarketMarket Growth Rate

LTE Base Station System MarketMarket Forecast

Global Virtual Commissioning MarketMarket Size

Automotive Seat Frame MarketMarket Growth

Gas Barbecues MarketMarket Analysis

Active Nutrition MarketMarket Size

Global Document Scanning Services MarketMarket Share

Global Interactive Projector MarketMarket Growth

Cloud Computing Stack Layers MarketMarket

Organic Fruits and Vegetables MarketMarket Share

Smart Meter MarketMarket Growth Rate

E-prescribing MarketMarket Forecast

Global 5-hydroxymethylfurfural (5-HMF) (CAS 67-47-0) MarketMarket Size

Acrolein Diethyl Acetal MarketMarket Growth

Inflatable Boats MarketMarket Analysis

Automotive Dual Variable Valve Timing MarketMarket Size

Global Electroplating Equipment MarketMarket Share

Global Construction Composite MarketMarket Growth

Fluorescent In Situ Hybridization Probe (Fish Probe) MarketMarket

Hard Luxury Goods MarketMarket Share

Fancy Yarn MarketMarket Growth Rate

Flame Detector MarketMarket Forecast

Global Epidural Anesthesia Sets MarketMarket Size

Automotive Hydroformed Parts MarketMarket Growth

Commercial Cooking Equipment MarketMarket Analysis

Vacuum Lamination Equipment MarketMarket Size

Global Autonomous Mobile Robot MarketMarket Share

Global Floor Cable Protectors MarketMarket Growth

Multi-Axial Simulation Table MarketMarket

GPS Bike Lock MarketMarket Share

0 notes

omkarpatel · 11 months ago

Text

Human Immunoglobulin (pH4) for Intravenous Injection is Estimated to Witness High Growth Owing to Rising Prevalence of Neurological and Immunodeficiency Diseases

Human immunoglobulin (pH4) is a blood plasma derived product administered intravenously for treatment of various neurological and immunodeficiency diseases. It contains antibodies which help strengthen the body's natural defenses against infectious agents. The rising incidences of immune deficiency disorders like agammaglobulinemia and common variable immunodeficiency have inflated the demand for immunoglobulin therapy. The global Human Immunoglobulin (pH4) for Intravenous Injection Market is estimated to be valued at US$ 17.5 billion in 2023 and is expected to exhibit a CAGR of 16% over the forecast period 2023-2031, as highlighted in a new report published by Coherent Market Insights. Market Opportunity: Rising prevalence of neurological and immunodeficiency diseases is estimated to witness high growth. Neurological disorders pose a significant healthcare burden globally and afflict millions worldwide each year. conditions like Guillain-Barre syndrome and chronic inflammatory demyelinating polyneuropathy require intravenous immunoglobulin as a mode of treatment. According to the World Health Organization, over 1 billion people suffer from some form of neurological disorder. The annual cost of neurological conditions in the U.S. alone is estimated to be over $800 billion. Thus, the growing cases of neurological diseases will spur demand for immunoglobulin therapy, acting as a high impact rendering driver for the market.

Porter’s Analysis Threat of new entrants: Low barrier to entry due to availability of raw material and manufacturing process knowledge. However, high capital requirements for production facilities and strong brand loyalty towards existing players limits threat. Bargaining power of buyers: Moderate bargaining power due to presence of substitutes. However, specialized production process results in inelastic demand. Bargaining power of suppliers: High dependence on plasma suppliers limits bargaining power. Suppliers can charge higher prices or refuse supply during shortages. Threat of new substitutes: Low threat as IgG products have no close substitute for treatment of certain immune disorders and deficiencies. Substitution requires regulatory approval and clinical trials. Competitive rivalry: Intense competition between major players. Companies compete based on product quality, reliability of supply, price and brand reputation. SWOT Analysis Strength: Established production facilities and regulatory approvals. Diversified product portfolio to treat range of conditions. Weakness: High capital intensity of production and vulnerability to plasma supply disruptions. Stringent regulatory norms increase compliance costs. Opportunity: Expanding patient population and increased diagnosis rate in developing regions. New clinical indications can boost revenue streams. Threats: Price controls and government reimbursement policies. Stringent import and export regulations across countries. Key Takeaways The global Human Immunoglobulin (pH4) for Intravenous Injection market is expected to witness high growth. The market is dominated by North America owing to high prevalence of immunodeficiency and autoimmune disorders. Rising healthcare spending and presence of major players in the US and Canada will drive the region's market share. Europe is the second largest regional market led by countries such as Germany, UK and France. Higher acceptance of IgG therapies and supportive national health strategies supplement the regional growth. Key players operating in the Human Immunoglobulin (pH4) for Intravenous Injection market are CSL Behring, Grifols, Baxter, Octapharma, Kedrion, CNBG, Hualan Bio and BPL. These players acquire plasma from approved donors and fractionate to produce standard and specialized IgG formulations.

#healthcare

0 notes

rohans18 · 1 year ago

Text

0 notes

industryupdate · 2 years ago

Text

Plasma Fractionation Industry To Grow Fastest In Oncology Category

The plasma fractionation market was valued at USD 28,605 million in 2022, and it is expected to reach a value of USD 50,638 million, growing at a rate of 7.4%, by 2030 as told in a report by P&S Intelligence.

The growth of this industry is mainly driven by the increasing elderly populace, which is vulnerable to numerous rare disorders that formulate the requirement for plasma derivatives for treatment.

During the pandemic, the demand for convalescent plasma increased as it is required for patient treatment, thus advancing the industry growth.

The immunoglobulins category is expected to witness significant growth, at a rate of 7.9%, in the years to come. This is credited to the commercial availability of plasma-derived immunoglobulins and their increasing use, mainly for treating defects related to immune systems or chronic inflammatory demyelinating polyneuropathy patients.

Immunoglobulins are the first line of treatment for numerous neurological, hematologic, and immunological disorders. The incidence of various immunological disorders has increased over the last decades.

North America held the largest revenue share of the industry, of approximately 55%. This is credited to the current development in the pharmaceutical research and development, the increasing number of plasma collection centers, rising paid plasma donation activities, the increasing population of hemophilic patients, growing product portfolios, and the existence of key players.

Moreover, Europe has the second-largest share of this industry. This is attributed to the increasing immunodeficiency and bleeding disorders, thus leading to increasing investments in these systems.

It is because of the increasing adoption of immunoglobulins in numerous therapies the expanding network of plasma collection facilities, and the growing incidence of respiratory problems, the plasma fractionation industry will experience considerable growth in the coming years.

#Plasma Fractionation #Healthcare #Life Sciences #Research #P&S Intelligence

1 note · View note

ken-research-market-research · 5 years ago

Photo

Global Plasma Fractionation Market Research Report And Outlook: Ken Research Buy Now The report covers the analysis and forecast of global plasma fractionation market as well as regional level.

0 notes

ameymeti2001 · 2 years ago

Text

Plasmapheresis Market Is Worth USD 1,285.3 Million By 2022

The global plasmapheresis market will grow at a CAGR of 8.3% during the forecast period to reach USD 1,285.3 million by 2022, according to this latest publication from Meticulous Research®. The global plasmapheresis market is driven by increasing demand for source plasma from biopharmaceutical companies, increasing the incidence of autoimmune diseases, and favorable reimbursement for therapeutic plasmapheresis procedure. However, the high cost of plasmapheresis devices & procedures and lack of awareness about apheresis collection among the population in emerging countries is expected to hamper the growth of plasmapheresis market during the forecast period.

Market Segmentation

Global plasmapheresis market is segmented by product type (instrument and disposables), by technology (membrane filtration and centrifugation), by applications (therapeutic plasmapheresis and source plasma collection), by end user (biopharmaceutical companies, hospitals & clinics, and others), and by geography (North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa).

Source plasma collection/donor plasmapheresis segment dominates the global plasmapheresis market and is also expected to increase significantly in the next 5-10 years. The large share of this segment is mainly attributed to increasing demand of source plasma from plasma fractionation industry and rising demand for plasma for transfusion in a patient with various diseases.

Geographic Overview

Geographically, the global plasmapheresis market is segmented into five major regions, namely North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. These regions are further analyzed at a country level with the detailed qualitative and quantitative analysis. North America accounted for the major share in the global plasmapheresis market in 2016, followed by Europe, and Asia-Pacific region. The major share of the North American region is mainly attributed to the higher adoption of plasmapheresis for source plasma collection in the U.S. & Canada, increasing incidence of autoimmune disorders, well-established healthcare system, and favorable reimbursement in the U.S. for TPE procedures performed in hospitals. However, Asian countries are slated to register the fastest growth during the forecast period, owing to the rising healthcare spending, rising living standards, increasing awareness about plasmapheresis procedure, and growing plasma fractionation industry.

Key players

The global plasmapheresis market is oligopolies with top three players accounting for major share of the market in 2016. The major players providing plasmapheresis instrument and disposables in the global plasmapheresis market are B. Braun Melsungen AG (Germany), Asahi Kasei Corporation (Japan), Baxter International Inc. (U.S.), Terumo Corporation (Japan), Kawasumi Laboratories Inc. (Japan), Haemonetics Corporation (U.S.), Fresenius SE & Co. KGaA (Germany), Kaneka Corporation (Japan), Infomed SA (Switzerland), and Shanghai Dahua Medical Apparatus Co., Ltd. (China).

Scope of the Report:

Plasma Fractionation Market, by Product

Immunoglobulins

Intravenous Immunoglobulins (IVIg)

Subcutaneous Immunoglobulins (SCIg)

Intramuscular Immunoglobulins (IMIg)

Coagulation Factors

Albumin

Protease Inhibitors

Other Products

Note: Other plasma-derived products include fibrin, sealant, and plasma

Plasma Fractionation Market, by Application

Immunology

Hematology

Neurology

Critical Care

Hematology-oncology

Rheumatology & Orthopedics

Other Applications

Note: Other applications include the management of respiratory diseases and wound healing.

Plasma Fractionation Market, by End User

Hospitals & Clinics

Clinical Research Laboratories

Academic & Research Institutes

Plasma Fractionation Market, by Geography

North America

U.S.

Canada

Europe

Germany

France

U.K.

Italy

Spain

Rest of Europe (RoE)

Asia-Pacific

China

Japan

India

Australia

Indonesia

Vietnam

Thailand

Malaysia

Rest of Asia-Pacific (RoAPAC)

Latin America

Brazil

Mexico

Columbia

Peru

Rest of Latin America (RoLATM)

Middle East & Africa

South Africa

Rest of Middle East & Africa

Download Sample Report -https://www.meticulousresearch.com/product/plasma-fractionation-market-5117?utm_source=PR&utm_medium=BLOG&utm_campaign=Product&utm_content=23-11-2022

0 notes

sanemyamen · 2 years ago

Text

Plasma Fractionation Market to Observe Strong Growth to Generate Massive Revenue in Coming Years

The Latest Released market study on Global Plasma Fractionation Market provides information and useful stats on market structure, size and trends. The report is intended to provide cutting-edge market intelligence and strategic insights to help decision makers take sound investment decisions and identify potential gaps and growth opportunities. Besides, the report also identifies and analyses changing dynamics, emerging trends along with essential drivers, challenges, opportunities and restraints in Plasma Fractionation market. What’s keeping CSL Limited (Australia),Grifols, S.A. (Spain),Shire Plc. (Ireland),Octapharma AG (Switzerland),Kedrion S.P.A (Italy),Bio Product Laboratory (United Kingdom),Sanquin (Netherlands),The LFB Group (France),Biotest AG (Germany) Keep Growing in the Market? Benchmark yourself with the strategic moves and latest Market Share and Sizing of Global Plasma Fractionation market recently published by AMA The Increasing effort to make procedures for fractioning proteins from plasma affordable is anticipated to drive the Global Plasma Fractionation market. Plasma is a blood component, derived from whole blood, and is used for various therapeutic and medical applications. Human plasma is a source of numerous different proteins, however, only a few of these proteins are useful for producing therapeutic plasma products. The process of separation, extraction, and purification of these proteins from the plasma is called as fractionation process. Plasma fractionation is the first process for large-scale protein purification, which was developed about 60 years ago by Cohn and co-workers. It is utilized in prevention as well as treatment of several severe diseases caused by immunologic disorders, trauma, and infections. Improved diagnostic facilities, and ease of access to improve healthcare along with the increasing incidences and prevalence of chronic diseases globally, are some factors responsible for the rising demand for plasma-derived products and is expected to drive the plasma fractionation market in the forecast period. The Plasma Fractionation Market segments and Market Data Break Down by Type (Immunoglobulins (Intravenous Immunoglobulins, Subcutaneous Immunoglobulins, Other Immunoglobulins), Coagulation Factor Concentrates (Factor VIII, Factor IX, Von Willebrand Factor, Prothrombin Complex Concentrates, Fibrinogen Concentrates, Factor XIII), Albumin, Protease Inhibitors, Other Plasma Products), Application (Neurology, Immunology, Hematology, Critical Care, Pulmonology, Hemato-Oncology, Rheumatology, Other Applications), End user (Hospitals & clinics, Clinical Research Laboratories, Academic institutes)

On the geographical front, the market has been segregated into North America (the United States and Canada), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia and others), Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia and others), Latin America (Brazil, Mexico and others), and Middle East and Africa. What’s Trending in Market : Development of new plasma proteins therapies (Ceruloplasmin, IgA, Plasmin) leading to innovative treatments for the benefits of patients

Increased usage of recombinant proteins and products acting as a substitute for the plasma products.

Market Challenges: Several pharmaceutical giants are developing a recombinant protein, which is anticipated to eat into the sales of plasma-derived proteins posing a challenge for the market.

Market Opportunities: Key vendors in the market are focusing on increasing the capacities of plasma fractionation and purification of a wide range of proteins, in turn providing an opportunity for the market.

Highlights of Influencing Drivers: Increasing geriatric population & demand for plasma protein

Therapeutic applications of plasma-derived protein & its rising indications

Growing investment in R & D leading to new innovations in new plasma protein therapies.

Presented By

AMA Research & Media LLP

0 notes

cool-akashy-maximize · 2 years ago

Text

Global Plasma Fractionation Market to Garner USD 46 Billion With CAGR of 6.89% And Forecast To 2029

Global Plasma Fractionation Market: was valued at US$ 27 Bn. in 2021. Global Plasma Fractionation Market size is expected to grow at a CAGR of 6.89 % through the forecast period.

Global Plasma Fractionation Market Overview:

For the Global Plasma Fractionation Market analysis, a research team conducted thorough primary and secondary research. Secondary research was carried out in order to supplement already-available data, segment the market, determine the total market size, and predict market size and growth rate. Market leaders are identified using primary and secondary research, which also determines market revenue. As part of the main study, extensive interviews with key thought leaders and business leaders, including CEOs and marketing executives, were undertaken.

Key opinion leaders and business leaders, including CEOs and marketing executives, were extensively interviewed as part of the primary study. The annual and financial reports of the major manufacturers were looked at as part of the secondary research. Market shares, growth rates, and breakdowns for the global market are generated from secondary sources and verified against primary data.

The report explores the Plasma Fractionation Market's segments (Connectivity and Content, and Region). Data has been provided by market participants, and regions (North America, Asia Pacific, Europe, Middle East & Africa, and South America). The MMR market report provides a thorough analysis of the rapid advances that are currently taking place across all industry sectors. Facts and figures, illustrations, and presentations are used to provide key data analysis for the historical period from 2017 to 2020. The report investigates the Plasma Fractionation Market's drivers, limitations, prospects, and barriers. This MMR report includes investor recommendations based on a thorough examination of the Plasma Fractionation Market's contemporary competitive scenario

Get A Free Sample Copy @ https://www.maximizemarketresearch.com/request-sample/6677

Market Scope:

By identifying and evaluating market categories and estimating market size, the study helps readers gain a deeper understanding of the dynamic structure of the global Global Plasma Fractionation market. The analysis compares the price, financial standing, application growth goals, and regional presence of the major firms. The study also includes a PESTLE analysis to help shareholders prioritise their efforts and investments in the global Global Plasma Fractionation market.

The examination of external and internal elements that are anticipated to help or hurt businesses has given decision-makers a clearer view of the market's future. The report also helps to understand the dynamic structure of the global ## market via the analysis of market segmentation and estimates of market size. By providing a detailed picture of the competitive analysis of important companies in the global Global Plasma Fractionation market based on price, financial situation, growth strategies, and geographic presence, the report serves as a resource for investors.

Global Plasma Fractionation Market Segmentation:

Based on the product type plasma fractionation market is segmented into Immunoglobulins, Coagulation Factor Concentrates, Albumin, Protease Inhibitors and Other.

The plasma fractionation market for immunoglobulin is the largest and is anticipated to increase at the fastest rate over the prediction period. The usage of immunoglobulins in a variety of conditions, including autoimmune diseases, inflammatory diseases, and primary and secondary immunological deficiencies, has contributed to the expansion of this market. Another factor driving the expansion of the immunoglobulin market is the spike in immunology-related research taking place all over the world.

To get a detailed report summary and research scope of the Global Plasma Fractionation Market, click here @ https://www.maximizemarketresearch.com/inquiry-before-buying/6677

Global Plasma Fractionation Market Key Players:

• Bio Products Laboratory • Biotest AG • China Biologic Products Holdings Inc. • CSL Limited • Green Cross Corporation • Grifols • Japan Blood Products Organization • Kedrion • LFB group • Octapharma AG • Sanquin Blood Supply Foundation • Takeda Pharmaceutical Company Limited. • Baxter • Green Cross Corporation • Shanghai RAAS • Bharat Serums and Vaccines Limited • Merck KGaA • ADMA Biologics • Boccard • Intas Pharmaceuticals Ltd.

Regional Analysis:

The Global Plasma Fractionation Market is investigated at the country level with an emphasis on countries with the largest market shares, categories, and categories with the potential for significant growth. North America (USA, Canada), South America, Asia Pacific (China, Japan, India, Korea), Europe (Germany, UK, France, Italy), and Other countries are the regions that make up the Global Plasma Fractionation Market study.

COVID-19 Impact Analysis on Global Plasma Fractionation Market: The report covers COVID-19 impact on Global Plasma Fractionation market.

Key Questions Answered in the Global Plasma Fractionation Market Report are:

What will the ## market's CAGR be over the course of the forecast period?

Which market category has risen to the top of the ## market?

What corporations rule the ## market?

What will the size of the ## market be in 2029?

Which business controlled the most share of the ## market?

About Maximize Market Research: Maximize Market Research, a global industry study business with a committed team of professionals and data, conducted extensive research on the Nuclear Medicinemarket. Syndicated and custom B2B and B2C business and market research on 12,000 high-growth emerging technologies, opportunities, and threats from Maximize Market Research can benefit companies in the chemical, healthcare, pharmaceuticals, electronics, and communications, internet of things, food and beverage, aerospace and defense, and other manufacturing sectors. Maximize Market Research is well-positioned to assess and forecast market size while also taking into account the competitive landscape of the sectors. Contact Maximize Market Research: 3rd Floor, Navale IT Park, Phase 2 Pune Banglore Highway, Narhe, Pune, Maharashtra 411041, India [email protected]

#Plasma Fractionation Market

0 notes

marketsandmarketshealth · 2 years ago

Text

Plasma Fractionation Market Reporting Market Size, Share, Growth, Trends, Analysis, Regional Outlook and Forecast 2026

Global Plasma Fractionation Market research report offers:

The global Plasma Fractionation market is defined, along with an analysis of several influencing factors like drivers, constraints, opportunities, & challenges.

Market risk analysis & industry trend analysis are also included in the Plasma Fractionation market.

The market competition landscape is defined, characterised, & analysed using Porter’s Five Force Analysis & SWOT analysis, with a focus on global primary manufacturers.

Identification and analysis of micro and macro aspects that influence & will influence market growth in the global Plasma Fractionation competitive landscape.

A comprehensive list of key market participants in the global Plasma Fractionation business.

It gives a descriptive assessment of demand-supply side analysis in the worldwide Plasma Fractionation market.

A statistical analysis of certain major economic indicators

The market is described using figures, charts, graphs, & drawings.

COVID-19 Impact on Plasma Fractionation market:

In the Plasma Fractionation market, the research also reveals exclusive choices, difficult situations, & problematic scenarios. A series of concepts will aid readers in making decisions & strategizing for their future chances. Our challenges, adversity, and market concerns let our readers realise how businesses might save them. The novel coronavirus illness (COVID-19) problem is wreaking havoc on all service & manufacturing businesses due to severe declines in demand. The majority of workforces in this arena are at risk. As an outcome, a considerable number of originalities have shut down.

The global crisis has impacted every industry. COVID-19’s market impact has been closely monitored by our analysts. A separate section of the report focuses on the setbacks which happened throughout the crisis.

Get access to a free copy of our latest sample report @

https://www.marketsandmarkets.com/requestsampleNew.asp?id=93798284

Introduction of the global Plasma Fractionation Market:

The intangible facts surrounding the key restraints, opportunities, & risks that are anticipated to affect the industry’s development during the forecast period are investigated in the Plasma Fractionation Market report (2022-2026). Other assessments, like supply & demand, imports & exports, distribution networks, consumption, and production capacity, are all important in giving business owners, stakeholders, & field marketers a competitive edge over competitors in the same arena. Furthermore, the research evaluates the Plasma Fractionation market competitors’ flaws & strengths in several categories. For business owners to establish real business plans, they must analyse previous & future major trends which are actively contributing to the growth of the Plasma Fractionation industry.

A complete analysis of the global Plasma Fractionation industry, as well as market segmentation by product type, applications, end-use, & region, is included in the report. The report includes a historical market dynamics analysis from 2022 to 2026, which will help readers compare past trends to current market scenarios, as well as key player contributions.

Regional Insights on Plasma Fractionation market:

The several sections on regional segmentation provide information on the regional characteristics of the global Plasma Fractionation Market. This chapter discusses the regulatory environment that will have an impact on the global market. It highlights the market’s political landscape & anticipates its impact on the worldwide Plasma Fractionation industry. Global brands’ presence and availability, as well as the problems they face from fierce competition from local & domestic brands, the influence of domestic tariffs, and trade channels, are all considered. The Plasma Fractionation report examines the five areas & their distribution by country:

North America – (U.S., Canada, and Mexico)

Europe – (U.K., Germany, France, Spain, Italy, Sweden, CIS Countries, and Rest of Europe)

Asia Pacific – (China, India, Japan, South Korea, Australia, ASEAN, and Rest of APAC)

Middle East & Africa – (South Africa, GCC Countries, Nigeria, Egypt, and Rest of ME&A)

South America – (Brazil, Argentina, Colombia, and Rest of South America)

Get access to a free copy of our latest Download PDF Brochure @

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=93798284

Segmentation:

The immunoglobins segment will witness the highest growth during the forecast period. Based on product, the plasma fractionation market is segmented into immunoglobulins, coagulation factor concentrates, albumins, protease inhibitors, and other products. The immunoglobulins segment accounted for the largest share of the plasma fractionation market in 2021. This segment is also expected to register the highest CAGR during the forecast period. The large share of this segment is attributed various off-label indications of immunoglobulin, applications of these drugs. Immunoglobulins are also used to combat the effects of immunosenescence or age-related changes in immunity. With the growing prevalence of infections and disorders, the use of immunoglobulins is expected to increase in the coming years.

The neurology segment dominated the plasma fractionation market in 2021. Based on application, the plasma fractionation market is segmented into neurology, immunology, hematology, critical care, pulmonology, hemato-oncology, rheumatology, and other applications. In 2021, the neurology segment accounted for the largest share of the plasma fractionation market. This is mainly due to the response of IVIg in a shorter period than steroids or oral immunosuppressants. IVIg is effective in a number of disorders of the peripheral and central nervous systems. IVIg is also being evaluated for other indications related to neurology, including Alzheimer’s disease. The positive results for these indications would increase the demand for IVIg in neurological applications.

Key Players:

Key players in the global plasma fractionation market include CSL (Australia), Grifols, S.A. (Spain), Shire (US), Octapharma AG (Switzerland), Kedrion S.P.A (Italy), LFB (France), Biotest AG (Germany), Sanquin (Netherlands), China Biologic Products Holdings Inc. (China), GC Pharma (Korea), Bio Products Ltd. (UK), Japan Blood Products Organization (Japan), Emergent BioSolutions (US), Shanghai Raas Blood Products Co., Ltd. (China), Intas Pharmaceuticals Ltd. (India), Bharat Serum Vaccines Limited (India), SK Plasma (Korea), Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. (China), KabaFusion (US), Centurion Pharma (Istanbul), ADMA Biologics, Inc. (US), PlasmaGen BioSciences Pvt. Ltd. (India), Virchow Biotech Private Limited (India), Fusion Healthcare (India), and Hemarus Therapeutics Limited (India).

Will You Have Any Questions About This Report? Please Contact Us On:

https://www.marketsandmarkets.com/Market-Reports/plasma-fractionation-market-93798284.html

0 notes

industryinsights · 3 years ago

Text

Chromatography Reagents Market Growth, Analysis, Region & Country Revenue Share, & Forecast Till 2027

According to MRFR analysis, the global chromatography reagents market is expected to register a CAGR of ~6.8% during the forecast period of 2021 to 2027 and is expected to account for USD 10,494 million by 2027.

Chromatography reagents are used for wide applications, including pharmaceutical drug development, clinical testing, the food & beverage industry, forensic science, and the petrochemical industry. Chromatography reagents such as gas chromatography reagents, liquid chromatography reagents, supercritical fluid chromatography, and thin-layer chromatography reagents are widely utilized for research applications. The growing demand for chromatography reagents for nucleic acid research, protein separation, enzyme purification, plasma fractionation, and other applications is likely to increase the growth rate of the chromatography reagents market globally. The growing utilization of chromatography in drug development and omics research is projected to influence chromatography reagents market growth over the forecast period.

Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/9167

The global chromatography reagents market is currently dominated by several market players. The key players are involved in geographic expansion, acquisition, and strategic collaborations to maintain their global footprint in the chromatography reagents market. Similarly, manufacturers and suppliers are extending their products and service offerings to support the growth of the chromatography reagents market. For instance, in March 2021, Alfa Chemistry (US) launched low pressure liquid chromatography (LPLC), thin layer chromatography (TLC), and paper chromatography product lines. It includes resins, separation media, agarose, silica gel, dextran gel, and other products. These reagents are used mainly in the research of industrial chromatography systems and technologies such as desalination systems, wastewater treatment, purification of biological products, and refining of sugar solutions. Apart from these initiatives, the technological advancements in the separation and purification techniques of solvents for testing biological products are propelling the growth of the chromatography reagents market.

Regional Analysis

The market has been divided into North America, Europe, Asia-Pacific, and the Rest of the World, based on region.

North America is likely to hold the largest market share in 2021, owing to the presence of a large number of pharmaceutical and biotechnology companies using high-performance liquid chromatography (HPLC) technologies. In addition, high government funding for research in the region is anticipated to foster the growth of the chromatography reagents market in North America in the near future. The chromatography reagents market in North America is divided into the US and Canada. Key companies such as Thermo Fisher Scientific (US), Avantor (US), Waters Corporation (US), Bio-Rad Laboratories, Inc. (US), Cytiva (US), Regis Technologies, Inc. (US), Santa Cruz Biotechnology (US), Agilent Technologies, Inc. (US), are facilitating research as well as analysis of products.

According to the 2020 EU Industrial R&D Investment Scoreboard published on 17th December 2020, companies in the European Union invested 5.6% more in R&D during 2019, up from 4.7% in 2018. The German company BioNTech SE, one of the first COVID-19 vaccine developers globally, increased its R&D expenditure by 284% and 158% in 2020 and 2019, respectively. BioNTech (Germany) received USD 445 million from the German government in September 2020. Chromatography is used for achieving maximum purity of vaccines in the downstream process. Thus, the large number of pharma and biotech companies, growing R&D expenditure, and government support for research are anticipated to increase the lucrativeness of the chromatography reagents market in the region during the forecast period. The European chromatography reagents market has been categorized into Germany, France, the UK, Italy, Spain, and the Rest of Europe. A rising number of clinical trials and associations engaged in finding better chromatography and electrophoretic separation techniques are supporting the growth of the chromatography reagents market in the region. For example, the 14th Congress of the French-speaking Association for Separative Sciences (SEP21) is expected to be held in Paris, France, from 5th–7th October 2021. It will cover new technologies, instrumentation, data processing, analytical development, and sample preparation across all applications of analytical sciences, including pharmaceuticals and cosmetics.

The chromatography reagents market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the Rest of Asia-Pacific. Traditional medicines are widely used in Asian countries such as India and China. Aristolochic acids are nephrotoxic and carcinogenic compounds and are widely added in Chinese herbal patent medicines. These acids are determined by the modified QuEChERS method in Chinese herbal patent medicines combined with the HPLC-MS analysis system. According to the WHO Global Report on Traditional and Complementary Medicine 2019, as of 2017, more than 60,000 traditional Chinese medicines have been approved, and 4,424 pharmaceutical enterprises have been granted manufacturing licenses. In 2015, the traditional Chinese medicine pharmaceutical industry accounted for 28.55% of the total value generated by the country’s pharmaceutical industry. An increasing number of pharmaceutical manufacturers, along with the rising application of chromatography to assess the purity and safety of traditional medicine, is anticipated to increase the market value in this region. The chromatography reagents market in Asia-Pacific is expected to be the fastest-growing during the forecast period. The market in the Rest of the World has been divided into the Middle East, Africa, and Latin America.

Segmentation

The global chromatography reagents market has been segmented based on type, technology, separation mechanism, and application.

The market, based on type, has been divided into solvents, buffers, derivatization reagents, ion-pair reagents, and others. The solvents segment is likely to hold maximum market share in 2021 owing to its larger utility globally.

The chromatography reagents market based on technology has been segmented into gas chromatography reagents, liquid chromatography reagents, supercritical fluid chromatography reagents, thin layer chromatography reagents, and others. The liquid chromatography reagents segment is anticipated to hold the largest share in the market due to its wide utility in laboratories for the separation of sample mixtures.

The chromatography reagents market based on separation mechanism has been segmented into adsorption chromatography, partition chromatography, ion-exchange chromatography, size-exclusion chromatography, affinity chromatography, and others.

The application segments of the chromatography reagents market are pharmaceutical testing, biopharma-biotech applications, research & academic applications, food & beverage testing, clinical testing, and others.

Key Players

Some of the key players in the global chromatography reagents market are Agilent Technologies, Inc. (US), Avantor (US), Bio-Rad Laboratories, Inc. (US), Chiron AS (Norway), Cytiva (US), GFS Chemicals Inc (US), Kanto Chemical (Japan), Loba Chemie Pvt. Ltd (India), Merck KGaA (Germany), Regis Technologies, Inc. (US), Restek (US), Santa Cruz Biotechnology (US), Spectrum Chemical Mfg. Corp. (US), Thermo Fisher Scientific (US), Tosoh Bioscience (Japan), and Waters Corporation (US).

Access full report @ https://www.marketresearchfuture.com/reports/chromatography-reagents-market-9167

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 628 258 0071

Email: [email protected]

0 notes

rohans18 · 1 year ago

Text

Middle East and Africa Plasma Fractionation Market Expected High Growth in Coming Years

Global Middle East and Africa Plasma Fractionation Market, By Product Type (Immunoglobulins, Coagulation Factor Concentrates, Albumin, Protease Inhibitors and Other Products), Application (Neurology, Immunology, Hematology, Critical Care, Pulmonology, Hemato- Oncology, Rheumatology and Others), Processing Technology (Ion- Exchange Chromatography , Affinity Chromatography, Cryopreservation, Ultrafiltration and Microfiltration), Mode (Modern Middle East and Africa Plasma Fractionation and Traditional Middle East and Africa Plasma Fractionation), End User (Hospitals & Clinics, Clinical Research Laboratories Academic Institutions and Others), Distribution Channel (Direct Tenders, Third Party Distribution and Others) , Country (U.S., Canada, Mexico, Germany, U.K., Italy, France, Spain, Switzerland, Netherlands, Russia, Turkey, Rest of Europe, Japan, China, South Korea, India, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel and Rest of Middle East and Africa) Industry Trends and Forecast to 2028.

An expert team performs systematic, object-oriented and complete market research study to provide the facts associated with any subject in the field of marketing via Middle East and Africa Plasma Fractionation marketing report. The report has a lot to offer to both established and new players in the Middle East and Africa Plasma Fractionation industry with which they can completely understand the market. SWOT analysis and Porter’s Five Forces analysis methods are used wherever applicable, while generating this report. One of the most important parts of an international Middle East and Africa Plasma Fractionation market report is competitor analysis with which businesses can estimate or analyse the strengths and weaknesses of the competitors.

Key Players

Some of the major players operating in the Middle East and Africa Plasma Fractionation market are Grifols, S.A., Takeda Pharmaceutical Company Limited, Octapharma AG, CSL Plasma, Japan Blood Products Organization, China Biologic Products Holdings, Inc., LFB SA, Green Cross Corp., Shanghai RAAS, Baxter, Bio Products Laboratory Ltd., Novasep Holding SAS, Pall Corporation, KabaFusion, Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd., Bharat Serums and Vaccines Limited (BSV), SK Plasma, Kedrion S.p.A, Sanquin, Biotest AG, Merck KGaA, ADMA Biologics, Inc., Boccard, Intas Pharmaceuticals Ltd. and CENTURION Ilaç Sanayi ve Ticaret A.S. among others. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Browse More Info @ https://www.databridgemarketresearch.com/reports/middle-east-and-africa-plasma-fractionation-market

With the help of credible Middle East and Africa Plasma Fractionation market analysis report, businesses can make out the reaction of the consumers to an already existing product in the market. The report includes estimations of recent state of the market, CAGR values, market size and market share, revenue generation, and necessary changes required in the future products. A wide-ranging competitor analysis helps build superior strategies of production, improvement in certain product, its advertising or marketing and promotion for the business. Exhaustive and comprehensive market study performed in the wide ranging Middle East and Africa Plasma Fractionation market report offers current and forthcoming opportunities that put light on the future market investment.

Key questions answered in the report:

Which product segment will grab a lion’s share?

Which regional market will emerge as a frontrunner in coming years?

Which application segment will grow at a robust rate?

Report provides insights on the following pointers:

Market Penetration: Comprehensive information on the product portfolios of the top players in the Middle East and Africa Plasma Fractionation Market.

Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and product launches in the market.

Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments of the leading players in the market.

Table Of Content

Part 01: Executive Summary

Part 02: Scope Of The Report

Part 03: Global Market

Part 04: Global Market Size

Part 05: Global Market Segmentation By Product

Part 06: Five Forces Analysis

More Reports:

Diuretic Drugs Market

Patient Engagement Technology Market

Healthcare Business Intelligence Market

Chinese Hamster Ovary cells (CHO) Market

Anti-cancer Drug Market

About Us:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market

Contact:

Data Bridge Market Research

Tel: +1-888-387-2818

Email: [email protected]

0 notes

marketresearchindia · 3 years ago

Text

Global Plasma Fractionation Market Size, Share, Growth and trends : ken Research

Buy Now

The Plasma Fractionation Market is anticipated to grow at the rate of 6.8% CAGR by 2026. In the plasma fractionation process, protein products are fractionated from human plasma to prevent and treat life-threatening conditions like immunologic disorders, congenital deficiencies, etc. Fractionation is a process supported to separate a certain quantity of a mixture. Additionally, plasma is the fluid component of blood that is fractionated to find different plasma derivatives such as albumin and immunoglobulins.

According to The Research Report “Plasma Fractionation Market by Product, Application (Hematology, Immunology, Neurology, Critical care, Pulmonology, Hemato-oncology, Rheumatology, and Other Applications), End-User, and Geography - Global Forecast up to 2026”These derived plasma products have therapeutic effects and are employed to treat several disorders related to blood plasma. Also, immunoglobulins are active in the treatment of primary and secondary immune deficiencies. Flow in the geriatric population across the world, which is disposed to many rare diseases that require plasma derivatives, is the main factor that increases the plasma fractionation market development.

Request For Sample Report- https://kenresearch.com/sample-report.php?Frmdetails=NDc2NzQ5

The rise in immunoglobulins and alpha-1-antitrypsin in medicine areas also fuels the plasma fractionation market's development. Additionally, the surge in plasma collection centers worldwide is another main factor contributing to this market's growth. Also, favorable government support to feast awareness related to the use of plasma resulting products propels the plasma fractionation market's development.

Plasma Fractionation Market by Product

Immunoglobulins

Intravenous Immunoglobulins

Subcutaneous Immunoglobulins

Other Immunoglobulins

Coagulation Factor Concentrates

Factor VIII

Factor IX

Von Willebrand Factor

Prothrombin Complex Concentrate

Fibrinogen Concentrates

Factor XIII

Albumin

Protease Inhibitors

Other Products

Plasma Fractionation Market by Application

Hematology

Immunology

Neurology

Critical care

Pulmonology

Hemato-oncology

Rheumatology

Other Applications

Plasma Fractionation Market by End User

Hospitals & Clinics

Clinical Research Laboratories

Academic Institutes

Plasma Fractionation Market by Geography

North America

Europe

Asia Pacific

Rest of the World

Based on the product, the immunoglobulins segment is happening to hold a significant share in the plasma fractionation market. This segment growth is ascribed to immunoglobulins' different uses in several disorders, including primary and secondary immune deficiencies and inflammatory diseases. Globally, an increase in the R&D associated with immunology is another factor boosting the demand for immunoglobulins.

In terms of application, the plasma fractionation applications consist of hematology, immunology, neurology, critical care, pulmonology, hemato-oncology, rheumatology, and other applications. The neurology segment is registered the maximum share in the market due to intravenous immunoglobulin in less time than steroids and its efficacy on several peripheral and central nervous system disorders.

The plasma fractionation market's end-users are hospitals and clinics, clinical research laboratories, and academic institutes. The significant end-users of plasma fractionation are hospitals and clinics. Hospitals require plasma products to treat acute diseases, and the increasing number of patients in hospitals is the reason for fueling the demand for plasma fractionation.

The North America region is leading the plasma fractionation market share during the forecast period. This is due to well-developed healthcare facilities, beneficial government regulations, and rising research and development in plasma fractionation are the factors responsible for the enormous expansion of the market in this region.

Immunoglobulins are employed as the primary remedy for several neurologic, immunologic and hematologic conditions. The most usual immunoglobulin therapy usage is to treat primary immune deficiencies and chronic inflammatory demyelinating polyradiculoneuropathy (CIDP). The diagnosis percentage of several immunological diseases has increased over the past few years due to technological advancements. Besides, globally increasing genetic research for identifying and diagnosing immunodeficiency will surge in the clinical requirement for immunoglobulins, increasing the global plasma fractionation market growth.

The profiles of companies leading the plasma fractionation market include Bharat Serums and Vaccines Limited, Shanghai RAAS Blood Products, Japan Blood Products Organization, Green Cross Corporation, Grifols, Shire, Octapharma, LFB, Biotest, CSL, Sanquin, China Biologic Products, Bio Products Laboratory, Kedrion, Emergent BioSolutions and Intas Biopharmaceuticals.

As a result, plasma fractionation is a vital class of remedies often utilized as the only choice available to prevent, manage, and treat fatal health conditions such as trauma, hereditary deficiencies, immunologic disorders, or infections.

This report delivers a comprehensive analysis of the plasma fractionation market growth drivers, restraints, opportunities, and other related challenges.

This report depicts the market developments such as new product launches, mergers and acquisitions, diversification, and joint ventures of the market players.

This report also describes all potential segments and sub-segments present in the market to help the companies in strategic business planning.

This report also gives the regional analysis of the plasma fractionation market in terms of market penetration across the world.

For More Information, refer to below link:-

Global Plasma Fractionation Market Research Report

Related Reports

Cell-Based Assays Market based on Product & Service (Consumables, Instruments, and Services), Application (Drug Discovery, Basic Research, and Other Applications), End-User, and Geography - Global Forecast up to 2026

Plasma Fractionation Market by Product, Application (Hematology, Immunology, Neurology, Critical care, Pulmonology, Hemato-oncology, Rheumatology, and Other Applications), End-User, and Geography - Global Forecast up to 2026

LinkedIn | Instagram | Facebook | Twitter | YouTube

Ken Research

Ankur Gupta, Head Marketing & Communications

[email protected]

+91-9015378249

#marketresearchreports #industrynews #business2business

0 notes

varsha582 · 3 years ago

Link

0 notes

ameymeti2001 · 2 years ago

Text

Plasmapheresis Market Is Worth USD 1,285.3 Million By 2022

Market Segmentation

Geographic Overview

Key players

Scope of the Report:

Plasma Fractionation Market, by Product

Immunoglobulins

Intravenous Immunoglobulins (IVIg)

Subcutaneous Immunoglobulins (SCIg)

Intramuscular Immunoglobulins (IMIg)

Coagulation Factors

Albumin

Protease Inhibitors

Other Products

Note: Other plasma-derived products include fibrin, sealant, and plasma

Plasma Fractionation Market, by Application

Immunology

Hematology

Neurology

Critical Care

Hematology-oncology

Rheumatology & Orthopedics

Other Applications

Note: Other applications include the management of respiratory diseases and wound healing.

Plasma Fractionation Market, by End User

Hospitals & Clinics

Clinical Research Laboratories

Academic & Research Institutes

Plasma Fractionation Market, by Geography

North America

U.S.

Canada

Europe

Germany

France

U.K.

Italy

Spain

Rest of Europe (RoE)

Asia-Pacific

China

Japan

India

Australia

Indonesia

Vietnam

Thailand

Malaysia

Rest of Asia-Pacific (RoAPAC)

Latin America

Brazil

Mexico

Columbia

Peru

Rest of Latin America (RoLATM)

Middle East & Africa

South Africa

Rest of Middle East & Africa

Download Sample Report -https://www.meticulousresearch.com/product/plasma-fractionation-market-5117?utm_source=PR&utm_medium=BLOG&utm_campaign=Product&utm_content=23-11-2022

0 notes

metiresearchinfo · 3 years ago

Text

TOP 10 COMPANIES IN CONTINUOUS BIOPROCESSING MARKET

The continuous bioprocessing market is expected to grow at a CAGR of 23.0% from 2021 to reach $429.12 million by 2028.

The growth of global continuous bioprocessing market is primarily driven by factors such as recent product launches in the continuous bioprocessing space, gradual adoption of continuous manufacturing, and global initiatives supporting the adoption of biopharmaceuticals. The shift towards bioprocessing 4.0, untapped markets in developing countries, and rising adoption of personalized medicines are expected to offer significant market opportunities.

Here are the top 10 companies operating in continuous bioprocessing market

3M Company

3M is a multinational conglomerate with expertise in product development, manufacturing, and marketing across various industries like consumer care, industrial safety, healthcare, and others. The company manages its operations across four business segments: Transportation and Electronics, Safety and Industrial, Consumer, and Health Care. The Health Care business segment offers oral care solutions, medical solutions, health information systems, separation and purification sciences, food safety, and drug delivery system. Separation and purification sciences include a comprehensive range of filtration products intended for the separation, classification, and purification of gases and fluids. The company provides a range of chromatography filters for biopharmaceutical applications like vaccines, recombinant proteins, chemical pharmaceuticals, and plasma fractionation.

3M sells its products through a number of distribution channels, including numerous ecommerce, retailers, traditional wholesalers, jobbers, dealers, and distributors and directly to users. The company operates 64 manufacturing facilities across 29 states in the U.S. Internationally, the company has over 97 manufacturing and converting facilities in 35 countries.

Cytiva

Cytiva is a provider of services and technologies to advance and accelerate the development and production of therapeutics. Previously, the biopharma business of GE Healthcare Life Sciences (U.S.), Cytiva is now a part of Danaher Corporation. The company offers its solutions for bioprocessing, cellular analysis, cell and gene therapy, diagnostics, enterprise solutions, genomics, lab filtration, and protein research. The company’s portfolio of bioprocessing solutions consists of upstream and downstream bioprocessing, enterprise solutions for bioprocessing, and FastTrack bioprocessing services. Upstream and downstream bioprocessing involves solutions for improving Xcellerex bioreactors, HyClone cell culture media, MabSelect chromatography resins, and ÄKTA systems. Enterprise solutions for bioprocessing involve KUBio facilities and Modular FlexFactory platforms for integrated platforms. FastTrack bioprocessing services include process development, collaborative training, and manufacturing services.

Cytiva has its presence across 40 locations covering North America, Europe, Asia, Latin America, and the Middle East, and Africa. As per the company’s data, in 2019, over 75% of biological therapies approved by the U.S. FDA used Cytiva’s technology for manufacturing.

Thermo Fisher Scientific, Inc.

Thermo Fisher Scientific, Inc. is a biotechnology company primarily engaged in accelerating life sciences research, solving complex analytical challenges, improving patient diagnostics, and increasing laboratory productivity. The company operates through its four reportable business segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services. The company’s life science segment consists of bioscience, genetic sciences, clinical next generation sequencing, and bioproduction. The company’s bioproduction offering includes single use bioproduction solutions, production cell culture media solutions, chromatography products, rapid molecular products, and scalable solutions for the manufacturing of cell therapy-based drugs.

The company sells and markets its products and services through electronic commerce, direct sales force, third party distributors, and customer service professionals. The company serves over 400,000 customers working in the biotech and pharma space, diagnostic labs, hospitals and clinics, research institutions, government agencies, universities, and environmental, industrial quality, and process control settings.

Merck KGaA

Merck KGaA is a science and technology company aimed to improve the health and wellbeing of people and advance their lives through science and technology. The company operates its business through three segments: Healthcare, Life Sciences, and Performance Materials. The Life Sciences business segment is further categorized into Research Solutions, Process Solutions, and Applied Solutions. Process solutions provide drug manufacturers with process development technologies and expertise, including continuous bioprocessing. The company operates in the continuous bioprocessing market through its Process Solutions business unit (a part of the Life Sciences segment).

The Life Science business sector has 59 manufacturing sites across the globe and more than 100 distribution centers. The sector has corporate offices, manufacturing units, and distributors across Argentina, Germany, France, Romania, Colombia, Japan, Brazil, Belgium, Croatia, the U.S., and Iraq, among others. The company’s life science segment serves various clients catered across a range of geographies, namely, North America, Europe, Asia Pacific, MEA, and Latin America.

Sartorious AG

Sartorious AG, assists biopharma research and development and manufacturing companies. The company conducts its operations through two divisions: Lab Product and Services and Bioprocess Solutions. The Bioprocess Solutions division offers products and services for biopharma production. Some of the technologies under Bioprocess Solutions include cell line technologies, bioreactors, cell culture media, products for the separation, purification and concentration, and storage and transportation products.

The company markets its products directly through sales representatives. The company expanded its direct sales operations in the Asia Pacific with the acquisition of a sales partner in Taiwan in 2012, particularly from Bioprocess Solutions. The company’s Bioprocess Solutions segment has a well-developed production network, with the largest production sites located across France, Germany, and Puerto Rico. The company also manufactures in Switzerland, India, the U.K., Tunisia, and the U.S.

Repligen Corporation

Repligen Corporation is a global life science company specializing in the development and commercialization of innovative bioprocessing technologies and systems, increasing flexibility and efficiencies in biologics manufacturing. The company’s bioprocessing business involves four main franchises: Filtration, Chromatography, Process Analytics, and Proteins. The chromatography franchise includes products for development, downstream purification, manufacturing, and quality control of biologics. The company entered the filtration technology market in 2014 after the acquisition of XCell Alternating Tangential Flow (“ATF”) assets from Refine Technology LLC (U.S.), which have applications in continuous cell culture processing. The company also has a portfolio of process analytics products complementing its product offering. Further, through the proteins segment, the company assists upstream bioprocessing.

The company’s bioprocessing products are majorly sold to biopharmaceutical development companies, life sciences companies, and contract manufacturing organizations. The company’s manufacturing facilities are located in Waltham, Massachusetts; Rancho Dominguez, Marlborough, Massachusetts, Texas; California; Irving, Lund, Sweden; Bridgewater, New Jersey; and Weingarten, Germany.

Eppendorf AG

Eppendorf AG is a life science company involved in the manufacturing and selling of laboratory instruments, consumables, and services. The company operates in four business segments: Separation & Instrumentation, Consumables, Liquid Handling, and Lab Solutions, under which it manufactures and sells products like manual and automatic pipettes, centrifuges, dispensers, spectrometers, mixers, DNA amplification equipment, fermenters and bioreactors, ultra-low temperature freezers, shakers, CO2 incubators, cell manipulation systems, single use bioreactor systems and consumables like test tubes, microtiter plates, and pipette tips.

The company has a direct presence in about 26 countries, and it is present in all other markets through distributors. As a part of the innovation initiative, the company had undertaken agile product development across its global operations in 2019, under which the company introduced about 20 products in 2019.

Applikon Biotechnology

Founded in 1973 and is headquartered in the Netherlands, Applikon Biotechnology develops and supplies advanced bioreactor systems from lab scale to pilot and production scale. The company supports the pharma industry and industrial microbiology in upstream processing by implementing scalable platforms from initial screening through full scale development. The company offers cultivation systems, process controls, software, turnkey systems, process analytics, perfusion, and integrated solutions for various industries like bio-fuels, pharma, regenerative medicine, academia, and food. The company’s Applikon BioSep System is a cell retention device for high quality perfusion processes, which uses a high frequency resonant ultrasonic waves for cell separation instead of physical membrane or mesh.

The company underwent facility expansion in June 2017. The company has a global distribution network covering over 35 countries. In December 2019, the company announced an acquisition of 100% shares in Applikon Biotechnology B.V. from Applikon Biotechnology Holding B.V. The company has an annual sale of USD 47.61 million (SEK 450 million)

Pall Corporation

Pall Corporation is a manufacturer of high tech separation, filtration, and purification instruments serving diverse needs of customers for various application industries. Pall Life Sciences and Pall Industrial are the primary operating segments of the company. The company’s life sciences business provides products and services that support the discovery, development, and production of medicinal products, including vaccines, biotech drugs, cell therapies, and pharmaceuticals. The life science offerings include depth filtration, sterile filtration, chromatography hardware, and purification platform, and bio containers.

The company is present across 80 locations worldwide. In 2015, Danaher Corporation (U.S.) completed the merger of U.S. based Pentagon Merger Sub, Inc, after which an indirect wholly owned subsidiary of Danaher Corporation, Pall Corporation, was formed.

Bionet

Incorporated in 1999 and headquartered in Mercia, Spain. Bionet is a manufacturer of laboratory, pilot, and industrial equipment and software for the bioprocessing industry. The company also provides bioprocess related services for the companies providing biomolecules through the cell culturing process and microbial fermentation. The company’s portfolio of bioprocessing solutions includes automation software solutions, bioreactors/fermenters, auxiliary equipment like cleaning in place systems, and tangential filtration. For industrial clients, the company provides complete bioproduction plants, integrating the company’s proprietary equipment with technologies like centrifuges, homogenizers from other vendors. The company also provides services like operation and maintenance activity, qualification, and technology election. Bionet is also part of international R&D institutions, organizations, and projects such as CETENMA, ASEBIO, CITEM, BRIDGE2020, GREENPGAS, PROGRAMA “HORIZONTE PYME”, GREEN PROTEIN, and FABRICACIÓN DEVACUNAS. The company has also been ISO 9001:2015, certified by AENOR for its quality management systems.

Amidst this crisis, Meticulous Research® is continuously assessing the impact of COVID-19 pandemic on various sub-markets and enables global organizations to strategize for the post-COVID-19 world and sustain their growth. Let us know if you would like to assess the impact of COVID-19 on any industry here- https://www.meticulousresearch.com/download-sample-report/cp_id=5079

Authoritative Research on the Continuous Bioprocessing Market – Global Opportunity Analysis and Industry Forecast (2021-2028)

Need more information? Meticulous Research®’s new report covers each of these companies in much more detail, providing analysis on the following:

Recent financial performance

Key products

Significant company strategies

Partnerships and acquisitions

The Impact of COVID-19 on the Continuous Bioprocessing Market

The Comprehensive report provides global market size estimates, market share analysis, revenue numbers, and coverage of key issues and trends.

Please download report pages and learn more:

Download Free Samlpe

0 notes